Patents by Inventor Martin Edward Swarbrick

Martin Edward Swarbrick has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Benzamide Derivatives As EP4 Receptor Agonists
    Publication number: 20130261185
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, R4, R5, m, n and X are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Application
    Filed: October 8, 2012
    Publication date: October 3, 2013
    Applicant: Glaxo Group Limited
    Inventors: Alessandra Gaiba, Mark Patrick Healy, Christopher Norbert Johnson, Susan Roomans, Steven James Stanway, Martin Edward Swarbrick
  • Benzamide derivatives as EPreceptor agonists
    Patent number: 8314147
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, R4, R5, m, n and X are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Grant
    Filed: December 12, 2007
    Date of Patent: November 20, 2012
    Assignee: Glaxo Group Limited
    Inventors: Alessandra Gaiba, Mark Patrick Healy, Christopher Norbert Johnson, Susan Roomans, Steven James Stanway, Martin Edward Swarbrick
  • Compounds
    Patent number: 8293798
    Abstract: A compound of formula (I) or salts thereof, wherein R1, R2, R3, R4, n and X are as defined in the specification; a process for preparing such compounds, a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Grant
    Filed: October 30, 2008
    Date of Patent: October 23, 2012
    Assignee: Glaxo Group Limited
    Inventors: Alessandra Gaiba, Susan Roomans, Martin Edward Swarbrick
  • NOVEL COMPOUNDS
    Publication number: 20100305166
    Abstract: A compound of formula (I) or salts thereof, wherein R1, R2, R3, R4, n and X are as defined in the specification; a process for preparing such compounds, a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Application
    Filed: October 30, 2008
    Publication date: December 2, 2010
    Inventors: Alessandra Gaiba, Susan Roomans, Martin Edward Swarbrick
  • NOVEL ISOINDOL DERIVATIVES AS EP4 RECEPTOR AGONISTS
    Publication number: 20100273853
    Abstract: A compound of formula (1) or a pharmaceutically acceptable derivative thereof, where R1, R2, R3, R4, R5, X and Y are as defined in the specification; corresponding processes for preparing; pharmaceutical compositions comprising; and medicinal uses of such compounds.
    Type: Application
    Filed: August 16, 2007
    Publication date: October 28, 2010
    Inventors: Gerard Martin Paul Giblin, Mark Patrick Healy, David George Livermore, Helen Susanne Price, Martin Edward Swarbrick
  • Benzamide Derivatives As EP4 Receptor Agonists
    Publication number: 20100022650
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, R4, R5, m, n and X are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Application
    Filed: December 12, 2007
    Publication date: January 28, 2010
    Inventors: Alessandra Gaiba, Mark Patrick Healy, Christopher Norbert Johnson, Susan Roomans, Steven James Stanway, Martin Edward Swarbrick
  • Novel compounds
    Publication number: 20080167377
    Abstract: A compound of formula (I) or a pharmaceutically acceptable derivative thereof, wherein, R1, R2, R3, R4, R5, m, n and X are as defined in the specification; a process for preparing such compounds; a pharmaceutical composition comprising such compounds; and the use of such compounds in medicine.
    Type: Application
    Filed: December 12, 2007
    Publication date: July 10, 2008
    Inventors: Alessandra Gaiba, Mark Patrick Healy, Christopher Norbert Johnson, Susan Roomans, Steven James Stanway, Martin Edward Swarbrick
  • Indole derivatives
    Patent number: 7288564
    Abstract: Compounds of formula (I) or salts or solvates thereof or physiologically functional derivatives thereof are potent binders at the EP4 receptor and are of use in the treatment or prevention of conditions such as a pain, inflammatory, immunological, bone, neurodegenerative or renal disorder.
    Type: Grant
    Filed: December 20, 2001
    Date of Patent: October 30, 2007
    Assignee: Glaxo Group Limited
    Inventors: Derek Anthony Demaine, Gerard Martin Paul Giblin, Rachel Elizabeth Hosking, Graham George Adam Inglis, Xiao Qing Lewell, Simon John Fawcett MacDonald, Andrew McMurtrie Mason, Martin Edward Swarbrick
  • Indole derivatives
    Publication number: 20040092569
    Abstract: Compounds of formula (I) 1
    Type: Application
    Filed: December 10, 2003
    Publication date: May 13, 2004
    Inventors: Derek Anthony Demaine, Gerard Martin Paul Giblin, Rachel Elizabeth Hosking, Graham George Adam Inglis, Xiao Qing Lewell, Simon John Fawcett MacDonald, Andrew McMurtrie Mason, Martin Edward Swarbrick